QWB

Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

Product code
QWB
Device name
Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens
Device class
Class 2
21 CFR
21 CFR 866.3984
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
2
Summaries archived here
1 (direct download)
510(k) clearances (all years, FDA)
3 (all years; only the last 3 years are listed here)

FDA classification definition

An over-the-counter molecular test to detect SARS-CoV-2 is an in vitro diagnostic device for the detection of SARS-CoV-2 in clinical specimens to aid in the diagnosis of SARS-CoV-2 infection. The device is intended to be used by lay users and without health care provider (HCP) intervention in home settings or similar environments.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (2)

Last three years. Most recent: 2026-08-07.

NumberDecision dateApplicantDevice nameSummary
K2534532026-08-07Aptitude Medical Systems, Inc.Metrix COVID Test; Metrix COVID Test ProPDF
K2326432023-11-28Cue Health, Inc.Cue COVID-19 Molecular TestFDA

1 summaries are archived here for direct download.

Official FDA classification page: QWB
Classification and pathway per current FDA publications. Data from openFDA (CC0).